Jansen Valerie Malyvanh has filed 8 insider transactions across 2 companies since February 2024.
Most recent transaction: a grant/award of 7650 shares of OnKure Therapeutics, Inc. ($OKUR) on May 28, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 28, 2025 | OnKure Therapeutics, Inc. | $OKUR | Jansen Valerie Malyvanh | Not found | A | Stock Option (right to buy) | 7650 | $0.00 | 7,650.0000 | 3,447,071 | 9999.99% | 0.22% |
| Feb. 15, 2025 | Elevation Oncology, Inc. | $ELEV | Jansen Valerie Malyvanh | CHIEF MEDICAL OFFICER | F | Common Stock | 5189 | $0.67 | 12,311.0000 | 57,275,454 | 29.65% | 0.01% |
| Feb. 15, 2025 | Elevation Oncology, Inc. | $ELEV | Jansen Valerie Malyvanh | CHIEF MEDICAL OFFICER | A | Stock Option (Right to Buy) | 275000 | $0.00 | 275,000.0000 | 57,275,454 | 9999.99% | 0.48% |
| Feb. 15, 2024 | Elevation Oncology, Inc. | $ELEV | Jansen Valerie Malyvanh | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 17500 | $0.00 | 52,500.0000 | 36,522,716 | 25.00% | 0.05% |
| Feb. 15, 2025 | Elevation Oncology, Inc. | $ELEV | Jansen Valerie Malyvanh | CHIEF MEDICAL OFFICER | M | Common Stock | 17500 | $0.00 | 17,500.0000 | 57,275,454 | 9999.99% | 0.03% |
| Oct. 4, 2024 | OnKure Therapeutics, Inc. | $OKUR | Jansen Valerie Malyvanh | Not found | A | Stock Option (right to buy) | 15300 | $0.00 | 15,300.0000 | 316,142 | 9999.99% | 4.84% |
| Feb. 15, 2024 | Elevation Oncology, Inc. | $ELEV | Jansen Valerie Malyvanh | CHIEF MEDICAL OFFICER | A | Restricted Stock Unit | 70000 | $0.00 | 70,000.0000 | 36,522,716 | 9999.99% | 0.19% |
| Feb. 15, 2024 | Elevation Oncology, Inc. | $ELEV | Jansen Valerie Malyvanh | CHIEF MEDICAL OFFICER | A | Stock Option (Right to Buy) | 225000 | $0.00 | 225,000.0000 | 36,522,716 | 9999.99% | 0.62% |